A detailed history of Operose Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Operose Advisors LLC holds 219 shares of ZTS stock, worth $39,152. This represents 0.01% of its overall portfolio holdings.

Number of Shares
219
Previous 219 -0.0%
Holding current value
$39,152
Previous $37,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $28,329 - $34,189
-171 Reduced 43.85%
219 $37,000
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $8,480 - $11,205
56 Added 16.77%
390 $76,000
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $55,824 - $64,385
334 New
334 $58,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.